153 related articles for article (PubMed ID: 23639362)
61. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
62. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Kato H; Kurosaki R; Oki C; Araki T
Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
[TBL] [Abstract][Full Text] [Related]
63. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
Zhang Y; Bhavnani BR
BMC Neurosci; 2005 Feb; 6():13. PubMed ID: 15730564
[TBL] [Abstract][Full Text] [Related]
64. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
Sharma A; Kaur P; Kumar V; Gill KD
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
[TBL] [Abstract][Full Text] [Related]
65. Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.
Choi JG; Kim HG; Kim MC; Yang WM; Huh Y; Kim SY; Oh MS
J Ethnopharmacol; 2011 Mar; 134(2):414-21. PubMed ID: 21195155
[TBL] [Abstract][Full Text] [Related]
66. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease.
Bae N; Ahn T; Chung S; Oh MS; Ko H; Oh H; Park G; Yang HO
J Ethnopharmacol; 2011 Mar; 134(2):313-22. PubMed ID: 21172413
[TBL] [Abstract][Full Text] [Related]
67. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
[TBL] [Abstract][Full Text] [Related]
68. Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Bourque M; Morissette M; Di Paolo T
Neurobiol Aging; 2014 Oct; 35(10):2347-56. PubMed ID: 24726471
[TBL] [Abstract][Full Text] [Related]
69. GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.
Castro-Caldas M; Neves Carvalho A; Peixeiro I; Rodrigues E; Lechner MC; Gama MJ
J Mol Neurosci; 2009 Jun; 38(2):114-27. PubMed ID: 18792812
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.
Rodriguez-Perez AI; Dominguez-Meijide A; Lanciego JL; Guerra MJ; Labandeira-Garcia JL
Neurobiol Dis; 2013 Oct; 58():209-19. PubMed ID: 23774254
[TBL] [Abstract][Full Text] [Related]
71. Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice.
Kavitha M; Nataraj J; Essa MM; Memon MA; Manivasagam T
Chem Biol Interact; 2013 Nov; 206(2):239-47. PubMed ID: 24095822
[TBL] [Abstract][Full Text] [Related]
72. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.
Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC
Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498
[TBL] [Abstract][Full Text] [Related]
73. Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres.
Yu X; Yao JY; He J; Tian JW
Life Sci; 2015 Mar; 124():136-43. PubMed ID: 25640758
[TBL] [Abstract][Full Text] [Related]
74. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
[TBL] [Abstract][Full Text] [Related]
75. Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1.
Liu J; Wang F; Liu S; Du J; Hu X; Xiong J; Fang R; Chen W; Sun J
J Neurol Sci; 2017 Oct; 381():176-181. PubMed ID: 28991675
[TBL] [Abstract][Full Text] [Related]
76. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.
Bourque M; Morissette M; Di Paolo T
Neuropharmacology; 2015 Aug; 95():343-52. PubMed ID: 25892506
[TBL] [Abstract][Full Text] [Related]
77. Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
Aguirre P; Mena NP; Carrasco CM; Muñoz Y; Pérez-Henríquez P; Morales RA; Cassels BK; Méndez-Gálvez C; García-Beltrán O; González-Billault C; Núñez MT
PLoS One; 2015; 10(12):e0144848. PubMed ID: 26658949
[TBL] [Abstract][Full Text] [Related]
78. Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.
Kobayashi S; Muroyama A; Matsushima H; Yoshimura I; Mitsumoto Y
Neurol Sci; 2012 Feb; 33(1):195-9. PubMed ID: 21598008
[TBL] [Abstract][Full Text] [Related]
79. Neuroprotective Effect of Schisandra Chinensis on Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonian Syndrome in C57BL/6 Mice.
Li CL; Tsuang YH; Tsai TH
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31330885
[No Abstract] [Full Text] [Related]
80. In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's Disease.
Choi JG; Park G; Kim HG; Oh DS; Kim H; Oh MS
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
